glp-1 guidelines for weight loss medications safe to continue before surgery in patients with diabetes and obesity GLP-1 medications are powerful metabolic
Description
Were transforming Hair Loss Awareness Month into Hair Growth Awareness Month
Lancet (1974) 2(7871):15
Some patients unconsciously or deliberately increase caloric intake during non-suppressed periods or consume calorie-dense beverages that don't trigger the same satiety response as solid foods
At the time of the study in early 2024, about 0.5% of the adult population in the US was using GLP - 1 therapies
patients spending $40 billion on appetite-suppressing drugs in 2024a figure that is projected to triple by 2030, according to Grand View Research
